Daewon Pharmaceutical Co. Ltd. (003220) — Cash Flow Reinvestment Rate
Daewon Pharmaceutical Co. Ltd. (003220) has a Cash Flow Reinvestment Rate of 1.25x as of March 2026, reinvesting ₩11.52 Billion (capex ₩11.26 Billion plus investments ₩-261.35 Million) from operating cash flow of ₩9.21 Billion. See Daewon Pharmaceutical Co. Ltd. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Daewon Pharmaceutical Co. Ltd. Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for Daewon Pharmaceutical Co. Ltd. across 15 annual periods. Explore 003220 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Daewon Pharmaceutical Co. Ltd. (2011–2025)
Year-by-year capital reinvestment analysis for Daewon Pharmaceutical Co. Ltd.. For the full cash flow conversion analysis, see cash efficiency ratio of Daewon Pharmaceutical Co. Ltd..
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.14x | ₩48.21 Billion | ₩42.31 Billion | ₩42.13 Billion | ▼ -48.1% |
| 2024 | 2.20x | ₩65.99 Billion | ₩30.04 Billion | ₩53.58 Billion | ▲ +27.9% |
| 2023 | 1.72x | ₩88.88 Billion | ₩51.73 Billion | ₩20.61 Billion | ▲ +39.5% |
| 2022 | 1.23x | ₩41.05 Billion | ₩33.33 Billion | ₩13.37 Billion | ▲ +35.6% |
| 2021 | 0.91x | ₩20.36 Billion | ₩22.41 Billion | ₩4.10 Billion | ▲ +99.2% |
| 2020 | 0.46x | ₩11.38 Billion | ₩24.95 Billion | ₩11.35 Billion | ▼ -68.8% |
| 2019 | 1.46x | ₩45.24 Billion | ₩30.97 Billion | ₩33.03 Billion | ▲ +39.8% |
| 2018 | 1.04x | ₩41.81 Billion | ₩40.03 Billion | ₩40.82 Billion | ▼ -72.8% |
| 2017 | 3.84x | ₩16.39 Billion | ₩4.27 Billion | ₩14.71 Billion | ▲ +96.1% |
| 2016 | 1.96x | ₩40.74 Billion | ₩20.79 Billion | ₩20.57 Billion | ▲ +142.1% |
| 2015 | 0.81x | ₩20.89 Billion | ₩25.82 Billion | ₩19.80 Billion | ▼ -21.5% |
| 2014 | 1.03x | ₩17.98 Billion | ₩17.45 Billion | ₩15.84 Billion | ▼ -24.7% |
| 2013 | 1.37x | ₩16.85 Billion | ₩12.32 Billion | ₩9.85 Billion | ▲ +472.4% |
| 2012 | 0.24x | ₩3.30 Billion | ₩13.83 Billion | ₩3.30 Billion | ▼ -58.0% |
| 2011 | 0.57x | ₩10.19 Billion | ₩17.93 Billion | ₩10.19 Billion | — |